Mild cognitive impairment: Animal models

Dialogues in Clinical Neuroscience

Volumn 6, Issue 4, 2004, Pages 369-377

  Pepeu, Giancarlo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Age dependent memory deficit; Aging monkey; Aging mouse; Aging rat; Transgenic mouse

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PRESENILIN 1;

AMNESIA; BRAIN BLOOD VESSEL; BRAIN ISCHEMIA; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; FEEDING BEHAVIOR; MEMORY DISORDER; MONKEY; MOTOR ACTIVITY; NEUROPATHOLOGY; NONHUMAN; PATHOLOGY; PROTEIN EXPRESSION; REVIEW; TRANSGENIC MOUSE;

EID: 11144247767     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. DeCarli C, Miller BL, Swan GE, et al. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung and Blood Institute Twin Study. Arch Neurol. 2001;58:643-647.
2. Grundman M, Petersen RC, Ferris SH, et al. Mild cognitive impairment can be distinguished from Alzheimer diseases and normal aging for clinical trials. Arch Neurol. 2004;61:59-66.
3. Pepeu G. Overview and perspective on the therapy of Alzheimer's disease from a preclinical viewpoint. Prog Neuropsychopharmacol Biol Psychiatry. 2001;25:193-209.
4. McDonald MP, Overmier JB. Present imperfect: a critical review of animal models of the mnemonic impairments in Alzheimer's disease. Neurosci Biobehav Rev. 1998;22:99-120.
5. Petersen RC, Doody R, Kurz A, et al. Current concept in mild cognitive impairment. Arch Neurol. 2001;58:1985-1992.
6. Sarter M, Hagan J, Dudchenko P. Behavioral screening for cognition enhancers: from indiscriminate to valid testing. Part I. Psychopharmacol (Berl). 1992;107:144-159.
7. Paoli F, Spignoli G, Pepeu G. Oxiracetam and D-pyroglutamic acid antagonize a disruption of passive avoidance behaviour induced by the N-methyl-D-aspartate receptor antagonist 2-amino-5-phosphonovalerate. Psychopharmacol (Berl). 1990;100:130-131.
8. McNamara PK, Skelton RW. Assessment of a cholinergic contribution to chlordiazepoxide-induced deficits of place learning in the Morris water maze. Pharmacol Biochem Behav. 1992;41:529-538.
9. Pepeu G. Overview and perspective on the therapy of Alzheimer's disease from a preclinical viewpoint. Prog Neuropsychopharmacol Biol Psychiatry. 2001;25:193-209.
10. Nakamura S, Ohno T. Spatial learning impairment in aged rats: comparing between aged basal forebrain lesioned and normal aged rats. Behav Brain Res. 1995;70:69-76.
11. Pepeu G, Marconcini Pepeu I, Casamenti F. The validity of animal models in the search for drugs for the aging brain. Drug Design Delivery. 1990;7:1-10.
12. Bartolini L, Casamenti F, Pepeu G. Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions. Pharmacol Biochem Behav. 1996;53:277-283.
13. Guan X, Dluzen DE. Age-related changes of social memory/recognition in male Fischer 344 rat. Behav Brain Res. 1994;61:87-90.
14. Fuchs A, Martin JR, Bender R, Harting J. Avoidance acquisition in adult and senescent rats. Gerontology. 1986;32:91-96.
15. Granger R, Deadwyler S, Davis M, et al. Facilitation of glutamate receptors reverses an age-associated memory impairment in rats. Synapse. 1996;22:332-337.
16. Fisher W, Chen K, Gage FH, Björklund A. Progressive decline in spatial learning and integrity of the forebrain cholinergic neurons in rats during aging. Neurobiol Aging. 1991;13:9-23.
17. Greferath U, Bennie A, Kourakis A, Barrett GL. Impaired learning is associated with loss of P75-positive neurons of the basal forebrain. Neuroscience. 2000;100:363-373.
18. Lindner MD, Balch HA, VanderMaelen CP. Short form of " reference" and "working-memory" Morris water maze for assessing age-related deficits. Behav Neural Biol. 1992;58:94-102.
19. Dunnett SB, Evenden JL, Iversen SD. Delay-dependent short-term memory deficits in aged rats. Psychopharmacology. 1988;96:174-180.
20. 2 antagonist, on spatial memory performance in adult and aged rats. Behav Neural Biol. 1992;58:113-119.
21. Takefumi K, Toshiyuki T, Tsugio K. Age-related working memory deficits in the allocentric place discrimination task: possible involvement in cholinergic dysfunction. Neurobiol Aging. 1999;20:629-636.
22. Smith JW, Al-Khamees O, Costall B, et al. Chronic aspirin ingestion improves spatial learning in adult and aged rats. Pharmacol Biochem Behav. 2002;71:233-238.
23. Winocur G. Environmental influences on cognitive decline in aged rats. Neurobiol Aging. 1998;19:589-597.
24. Wyss JM, Chambless BD, Kadish I, van Groen T. Age-related decline in water maze learning and memory in rats: strain differences. Neurobiol Aging. 2000;21:671-681.
25. Jeglinski W, Pepeu G, Oderfeld-Nowak B. Differential susceptibility of senile and lesion-induced astrogliosis to phosphatidylserine. Neurobiol Aging. 1997;18:81-86.
26. Wu CF, Bertorelli R, Sacconi M, et al. Decrease of brain acetylcholine release in aging freely moving rats detected by microdialysis. Neurobiol Aging. 1988;9:357-361.
27. Gallangher M, Bizon JL, Hoyt EC, et al. Effects of aging on the hippocampal formation in a natural occurring animal model of mild cognitive impairment. Exp Gerontol. 2003;38:71-77.
28. Vannucchi MG, Casamenti F, Pepeu G. Decrease in acetylcholine release from cortical slices in aged rats: investigations into its reversal by phosphatidylserine. J Neurochem. 1990;55:819-825.
29. Scali C, Casamenti F, Pazzagli M, et al. Nerve growth factor increases extracellular acetylcholine levels in the parietal cortex and hippocampus of aged rats and restores object recognition. Neuroscience Lett. 1994;170:117-120.
30. Wilkie F, Eisdorfer C. Intelligence and blood pressure in the aged. Science. 1971;172:157-174.
31. Elias MF, Wolf PA, D'Agostino RB, et al. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol. 1993;138:353-364.
32. Prencipe M, Santini M, Casini AR, et al. Prevalence of non-dementing cognitive disturbances and their association with vascular risk factors in an elderly population. J Neurol. 2003;250:907-912.
33. DeCarli C. Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment. Lancet Neurol. 2003;2:15-25.
34. Wyss JM, Fisk G, van Groen T. Impaired learning and memory in mature spontaneously hypertensive rats. Brain Res. 1992;592:135-140.
35. Hernandez CM, Høifødt H, Pharm C, Terry AV. Spontaneously hypertensive rats: further evaluation of age-related memory performance and cholinergic marker expression. J Psychiatry Neurosci. 2003;28:197-209.
36. Terry AV, Hernandez CM, Buccafusco JJ, Gattu M. Deficits in spatial learning and nicotinic-acetylcholine receptors in older, spontaneously hypertensive rats. Neuroscience. 2000;101:357-368.
37. Lindeboon J, Weinstein H. Neuropsychology of cognitive aging, minimal cognitive impairment, Alzheimer's disease, and vascular cognitive impairment. Eur J Pharmacol. 2004;490:83-86.
38. Sabbatini M, Catalani A, Consoli C, et al. The hippocampus in spontaneously hypertensive rats: an animal model of vascular dementia? Mech Ageing Dev. 2002;123:547-559.
39. Wyss JM, Kadish I, van Groen T. Age-related decline in spatial learning and memory: attenuation by captopril. Clin Exp Hypertens. 2003;25:455-474.
40. Banfi S, Dorigotti L. Experimental behavioural studies with oxiracetam on different types of chronic cerebral impairment. Clin Neuropharmacol. 1986;8(suppl 3):S19-S26.
41. Higgins GA, Enderlin M, Fimbel R, et al. Donepezil reverses a mnemonic deficit produced by scopolamine but not by perforant path lesion or transient cerebral ischemia. Eur J Neurosci. 2002;15:1827-1840.
42. Cain DP, Boon F. Detailed behavioural analysis reveals both task strategies and spatial memory impairments in rats given bilateral middle cerebral artery stroke. Brain Res. 2003;972:64-74.
43. Nunn J, Hodges H. Cognitive deficits induced by global cerebral ischemia: relationship to brain damage and reversal by transplants. Behav Brain Res. 1994;65:1-31.
44. Dean RL, Scozzafava J, Goas JA, et al. Age-related differences in behaviour across the life span of the C57BL/6J mouse. Exp Aging Res. 198;7:427-451.
45. Sauer H, Francis JM, Jiang H, et al. Systemic treatment with GPI 1046 improves spatial memory and reverses cholinergic neuron atrophy in the medial septal nucleus of aged mice. Brain Res. 1999;842:109-118.
46. Chen G, Chen KS, Knox J, et al. A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease. Nature. 2000;408:975-979.
47. Yamaguchi F, Richards SJ, Beyreuther K, et al. Transgenic mice for the amyloid precursor protein 695 isoform have impaired spatial memory. Neuroreport. 1991;2:781-784.
48. Westerman MA, Cooper-Blacketer D, Mariash A, et al. The relationship between Aβ and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci. 2002;22:1858-1867.
49. Ikarashi Y, Harigaya Y, Tomidokoro Y, et al. Decreased level of brain acetylcholine and memory disturbance in APPsw mice. Neurobiol Aging. 2004;25:483-490.
50. Janus C, Pearson J, McLarin J, et al. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature. 2000;408:979-982.
51. Morgan D, Diamond DM, Gottschall PE, et al. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature. 2000;408:982-985.
52. Liu L, Ikonen S, Heikkinen T, et al. The effects of long-term treatment with metrifonate, a cholinesterase inhibitor, on cholinergic activity, amyloid pathology, and cognitive function in APP and PS1 doubly transgenic mice. Exp Neurol. 2002;173:196-204.
53. Stackman RW, Eckestein F, Frei B, et al. Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment. Exp Neurol. 2003;184:510-520.
54. Bartus RT, Dean RL, Fleming DL. Aging in the rhesus monkey: effects on visual discrimination learning and reversal learning. J Gerontol. 1979;34:209-219.
55. Bartus RT. Effects of aging on visual memory, sensory processing, and discrimination learning in a nonhuman primate. In: Ordy JM, Brizee K, eds. Sensory Systems and Communication in the Elderly (Aging Vol 10). New York, NY: Raven Press; 1979:85-114.
56. Erickson CA, Barnes CA. The neurobiology of memory changes in normal aging. Exp Gerontol. 2003;38:61-69.
57. Rapp PR, Amaral DG. Recognition memory deficits in a subpopulation of aged monkeys resemble the effects of medial temporal lobe damage. Neurobiol Aging. 1991;12:481-486.
58. Rapp PR, Amaral DG. Evidence for task-dependent memory dysfunction in the aged monkey. J Neurosci. 1989;9:3568-3576.
59. Bachevalier J. Behavioral changes in aged rhesus monkeys. Neurobiol Aging. 1993;14:619-621.
60. Dean RL, Bartus RT. Animal models of geriatric cognitive dysfunction: evidence for an important cholinergic involvement. In: Traber J, Gispen WH, eds. Senile Dementia of the Alzheimer's Type. Berlin, Germany: Springer Verlag; 1985:269-282.
61. Tsukada H, Nishiyama S, Fukumoto D, et al. Effects of acute acetyl-cholinesterase inhibition on the cerebral cholinergic neuronal system and cognitive function: functional imaging of the conscious monkey brain using animal PET in combination with microdialysis. Synapse. 2004;52:1-10.
62. Bartus RT, Dean RL, Beer B. Neuropeptide effects on memory in aged monkeys. Neurobiol Aging. 1982;3:61-68.
63. 1 receptor stimulation. J Neurosci. 2004;24:1446-1450.
64. Arnsten AFT, Goldman-Rakic PS. Analysis of alpha-2 adrenergic agonist effect on the delayed nonmatch-to-sample performace of aged rhesus monkeys. Neurobiol Aging. 1990;11:583-590.
65. Buccafusco JJ, Weiser T, Winter K, et al. The effects of IDRA 21, a positive modulator of the AMPA receptor, on delayed matching performance by young and aged rhesus monkeys. Neuropharmacology. 2004;46:10-22.